Skip to main content
. 2016 Feb 18;2016(2):CD007874. doi: 10.1002/14651858.CD007874.pub2

Byon 2014.

Methods Double‐blind randomized controlled trial
Participants Age 20 years to 65 years, ASA I or II, injected with propofol for general anaesthesia
Exclusion criteria: ischaemic heart diseases, neurologic problems, pregnancy, breast‐feeding women, administration of analgesics within 24 hours before surgery, allergic to propofol or its contents (soy‐bean oil, MCT, glycerol, egg lecithin, and sodium oleate), and allergic to lidocaine.
Recruitment: 234 participants were randomly assigned (117 participants in each group)
Setting: Korea
Interventions Pretreatment alone
Admixture
The pretreatment group was injected with a 40 mg solution of 2% lidocaine at the distal‐most part of the intravenous line, flushed with 3 ml of normal saline. One minute later, propofol 2 mg/kg with 2 ml of normal saline solution was injected
The premixed group was pretreated with a tourniquet with 2 ml of normal saline, then flushed with 3 ml of normal saline. Then one minute later, propofol 2 mg/kg with a 40 mg solution of 2% lidocaine was injected
All of the agents were injected at the same rate of 1 ml/sec, as the drug infusion rate may affect the incidence of propofol injection pain
Outcomes Pain intensity assessed on 3‐point scale
No pain
Minor pain criteria included moaning and frowning
Major pain criteria included verbal expressions of pain and movement of hand with a look of withdrawing from pain
Other outcomes: pain incidence, adverse effects
Notes There was no control group